Taking a page out of playbook used to establish the framework that excludes products of certain Chinese telecommunications companies from the federal market (e.g., the “Huawei ban”), the BIOSECURE Act would prohibit the federal government from purchasing biotechnology equipment or services from certain “companies of concern.” The Act does not stop there. It would also
On July 11 at 10 AM, Thomas O’Linn, Senior Procurement Policy Analyst, Acquisition Policy Division of the Office of Government-Wide Policy at the General Services Administration, will be speaking at a meeting hosted by the Coalition's Furniture and Furnishings Committee to provide an update on the Eligibility Process for using GSA sources of supply (e.g.,
During the webinar, Stephen and Greg will discuss the critical distinctions between Average Manufacturer Price (AMP) and Weighted Average Manufacturer Price (WAMP) and their implications for both brand and generic drugs. Additionally, they will highlight and discuss a top issue impacting each program, providing you with the insights needed to stay compliant in this evolving landscape.
On July 16 at 2:00 PM (ET), the GWAC/MAC Committee is hosting a members-only meeting with Casey Kelley, Client Executive, AAS Army/Air Force, GSA. During the meeting, he will brief attendees on the latest updates and initiatives from GSA’s Assisted Acquisition Services (AAS), including AAS outlook and the status of its realignment efforts.
Join us on July 18 for an in-depth webinar focused on the Department of Veterans Affairs’ Federal Supply Schedule (FSS) Program. This session will explore five key aspects of an FSS contract that are recognized as essential by legal, pricing, compliance, finance, and contracts professionals.
As public law season rapidly approaches, it is crucial to stay informed and prepared, especially for drugs marketed under New Drug Applications (NDAs) and Biologics License Applications (BLAs). Join us on July 25 for a timely and informative webinar as Stephen Ruscus, Partner at BakerHostetler, and Greg Madden, Managing Member at Orlaithe Consulting, will guide you through the essential steps to navigate public law season.
On July 30, Erv Koehler, Assistant Commissioner, Office of General Supplies and Services at the General Services Administration and Michael Shepherd, Director, Catalog Management Office, will be joining the Coalition's General/Office Products Committee Meeting to discuss pricing tools, the delivery scorecard, and the overall state of the program. The meeting will be held virtually, please provide
The following CMMC webinar is open to Coalition and AMSUS-SM members.
On August 1, we are pleased to have Stephen Ruscus, Partner at BakerHostetler, and Greg Madden, Managing Member at Orlaithe Consulting, present an insightful webinar dedicated to understanding the evolving landscape of domestic sourcing requirements for brand drugs, generic drugs, and medical devices.
The Small Business Committee will be hosting John Klein, SBA Deputy General Counsel to provide a regulatory update and answer questions from members. The meeting will be held in-person at the Offices of Holland and Knight, 800 17th street NW, Washington DC, 20006. Virtual attendance will be available.
The IT/Services Committee Meeting will be hosting GSA's Bill Toth, Assistant Commissioner, Office of Customer and Stakeholder Engagement (CASE). The meeting will discuss the CASE office's initiatives for FY 2025 and plans for outreach to customer agencies. The meeting will be held in-person at CACI, 12021 Sunset Hills Rd #100, Reston, VA 20190, United States.
In recent years federal contractors have been challenged to adapt their legal and compliance strategy to a growing regulatory focus on securing the federal supply chain. In particular, technology bans and restrictions have been used to mitigate data security and surveillance concerns associated with foreign information and communications technology (ICT) – imposing significant new due